Tenon Medical Inc

Tenon Medical Inc (TNON) Stock Analysis

$1.770

+0.117 (+6.63%)At close

Loading chart…
High
1.800
Open
1.660
VWAP
1.74
Volume
94.11K
Mkt Cap
2.31M
Low
1.650
Amount
163.75K
EV/EBITDA, TTM
-0.37

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

AI analysis of Tenon Medical Inc (TNON)

Sell

Tenon Medical Inc is not a good buy right now due to its extremely low RSI of 13.34, indicating it is oversold, and a staggering year-to-date change of -95.13%. The stock is trading at $1.66, significantly below its 52-week high of $45.50, which reflects a severe decline in value. The company has also reported consistent net losses, with the latest EPS at -12.35, and a forward P/E ratio of 0, suggesting no earnings growth is expected in the near term. The main risk is the negative sentiment surrounding its financing activities, which caused a 4.79% drop in pre-market trading after the announcement of a securities purchase agreement.

Valuation Metrics

The current forward P/E ratio for Tenon Medical Inc (TNON) is 0.00, compared to its 5-year average forward P/E of -3.02.

Forward P/E

Fair
5Y Average P/E
-3.02
Current P/E
0.00
Overvalued
12.73
Undervalued
-18.77

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
-0.05
Current EV/EBITDA
-0.37
Overvalued
0.06
Undervalued
-0.17

Forward P/S

Fair
5Y Average P/S
5.63
Current P/S
0.50
Overvalued
36.11
Undervalued
-24.85

Alphio AI Price Scenarios for TNON

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%TNON

$1.25

Scenario price

B

Base

Base · 50%TNON

$1.02

Scenario price

B

Bear

Bear · 25%TNON

$0.83

Scenario price

Events Timeline

2026-10-28 (ET)

09:25:00

Tenon Medical Completes Initial Alpha Cases for Quickstep

2026-10-15 (ET)

09:00:00

Tenon Medical Secures 8 New Patents

2026-10-05 (ET)

06:30:00

Selling Stockholders Plan to Sell 858,269 Shares of Common Stock

2026-09-30 (ET)

09:00:00

Tenon Medical Launches New Titanium 3D-Printed Lateral Screw

2026-09-11 (ET)

11:00:00

Tenon Medical Inc Trading Halted

News

TNON FAQ — answered by Alphio AI

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Tenon Medical Inc is not a good buy right now due to its extremely low RSI of 13.34, indicating it is oversold, and a staggering year-to-date change of -95.13%. The stock is trading at $1.66, significantly below its 52-week high of $45.50, which reflects a severe decline in value. The company has also reported consistent net losses, with the latest EPS at -12.35, and a forward P/E ratio of 0, suggesting no earnings growth is expected in the near term. The main risk is the negative sentiment surrounding its financing activities, which caused a 4.79% drop in pre-market trading after the announcement of a securities purchase agreement.

Community

More ↗
Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading